Find Research Projects

Search results

• A 6-week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study, to Assess the Efficacy and Tegaserod (6mgBID) & Placebo in Female Patients with Dyspepsia

  Nickl, N.

  11/1/03 → 12/31/07

  Project: Research project

• A 6-Week Randomized, Multicenter, Double-Blind, Parallel, Fixed-Dose Study of MG01CI 1400mg Compared with Placebo in Adults with Attention Deficit/Hyperactivity Disorder (ADHD)

  Glaser, P.

  4/2/14 → 2/28/15

  Project: Research project

• A 6-Week Randomized, Parallel, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects with Irritability Associated with Autistic Disorder

  Glaser, P.

  1/7/14 → 3/27/15

  Project: Research project

• AACAP Physician Scientist Program in Substance Abuse

  Martin, C.

  6/1/20 → 5/31/21

  Project: Research project

• AACAP Physician Scientist Program in Substance Abuse

  Martin, C.

  9/15/09 → 5/31/13

  Project: Research project

• AACAP Physician Scientist Program in Substance Abuse

  Martin, C.

  9/15/09 → 5/31/14

  Project: Research project

• AACAP Physician Scientist Program in Substance Abuse

  Martin, C.

  9/15/09 → 5/31/12

  Project: Research project

• AACAP Physician Scientist Program in Substance Abuse

  Martin, C.

  6/1/20 → 5/31/22

  Project: Research project

• AACAP Physician Scientist Program in Substance Abuse

  Martin, C.

  6/1/20 → 5/31/25

  Project: Research project

• AACP Physician Scientist Program in Substance Abuse

  Martin, C.

  9/15/09 → 5/31/11

  Project: Research project

• AACP Physician Scientist Program in Substance Abuse

  Martin, C.

  9/15/09 → 5/31/10

  Project: Research project

• AAFCO Sampling Methods Study - Option 1

  Harrison, G. & Harrison, G.

  Association of American Feed Control Officials Incorporated

  10/1/20 → 9/30/21

  Project: Research project

• AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; NCI IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia ALL) or T-cell Lymphoblastic Lymphoma

  Badgett, J. & Radulescu, V.

  Public Health Institute

  11/28/18 → 8/30/23

  Project: Research project

• AALL07P1 Millennium Pharmaceuticals A Phase II Pilot Trial of Bortezomib in Combo iwth Intensive Re-Induction Therapy

  Greenwood, M.

  2/14/13 → 10/31/13

  Project: Research project

• AALL1131: Supplemental PCR

  Badgett, J.

  Childrens Hospital of Philadelphia

  8/1/20 → 7/31/21

  Project: Research project

• AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab in First Relapse of Childhood B-Lymphoblastic Leukemia

  Badgett, J., Radulescu, V. & Wagner, L.

  Public Health Institute

  5/15/21 → 8/30/23

  Project: Research project

• AALL1821: A Phase 2 Study of Blinatumomab (NSC# 765986, IND# 125462) in Combination with Nivolumab (NSC# 748726, IND# 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged #1 to <30 Years Old with First Relapse

  Badgett, J.

  Childrens Hospital of Philadelphia

  12/4/20 → 10/2/21

  Project: Research project

• AALL1821: A Phase 2 Study of Blinatumomab (NSC# 765986, IND# 125462) in Combination with Nivolumab (NSC# 748726, IND# 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged #1 to <30 Years Old with First Relapse

  Badgett, J.

  Public Health Institute

  12/4/20 → 6/8/23

  Project: Research project

• AAML1831: A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations

  Badgett, J.

  Childrens Hospital of Philadelphia

  7/20/20 → 1/13/22

  Project: Research project

• AAML1831: A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations

  Badgett, J.

  Public Health Institute

  7/20/20 → 11/10/22

  Project: Research project

• AAML1831: A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations

  Badgett, J.

  Childrens Hospital of Philadelphia

  3/18/21 → 1/13/22

  Project: Research project

• AAML1831: A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations

  Badgett, J.

  Public Health Institute

  3/18/21 → 9/7/23

  Project: Research project

• AAML18P1: Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

  Badgett, J.

  Public Health Institute

  4/5/21 → 5/11/23

  Project: Research project

• AAML18P1: Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

  Badgett, J.

  Childrens Hospital of Philadelphia

  4/5/21 → 9/9/21

  Project: Research project

• AASHTO NTPEP Concrete Coatings

  Hopwood, T., Jewell, R. & Palle, S.

  American Association of State Highway and Transportation

  2/14/14 → 12/31/18

  Project: Research project

• AB07002: A 96-Week, Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, 2-Parallel Group, Phase 3 Study to Compare Efficacy and Safety of Masitinib 6 mg/kg/Day/ Versus Placebo

  Berger, J.

  3/1/11 → 3/31/15

  Project: Research project

• AB19001: A Prospective, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Parallel Groups, Phase 3 Study to Compare the Efficacy and Safety of Masitinib in Combination with Riluzole Versus Placebo in Combination with Riluzole in the Treatment of

  Kasarskis, E.

  AB Science

  8/30/21 → 11/30/22

  Project: Research project

• AbatacepT foR ImmUne checkpoint inhibitor associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety Abatacept Compared to Placebo in Hospitalized Participant

  Arbune, A.

  Massachusetts General Hospital

  12/6/22 → 10/4/23

  Project: Research project

• Abatacept in Subject with Active Crohn's Disease

  De Villiers, W.

  8/1/07 → 7/31/10

  Project: Research project

• Abatacept in Subject with Active Ulcerative Colitis

  De Villiers, W.

  8/1/07 → 7/31/11

  Project: Research project

• Abbott Laboratories Symposium

  Grossman, R.

  Abbott Laboratories

  8/1/10 → 7/31/11

  Project: Research project

• ABBV-951 Discontinued Patient Initiative for M15-741

  Wagner, R.

  Clinical Score LLC

  6/1/20 → 9/30/20

  Project: Research project

• ABCG1 Function in Diabetes

  Daugherty, A.

  La Jolla Institute for Allergy & Immunology

  7/1/10 → 3/31/11

  Project: Research project

• ABCG1 Function in Diabetes

  Daugherty, A.

  University of Virginia

  5/1/08 → 9/25/09

  Project: Research project

• Abdelghaffar Salous Pre-Doc Fellowship: Role of Lipid Phosphatases in Dynamic Regulation of Lipid Metabolism and Signaling in Cardiovasculature

  Morris, A. & Salous, A.

  7/1/09 → 6/30/11

  Project: Research project

• Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis

  Sun, R., Allison, D., Brainson, C., Wang, C., Gentry, M. & Vander Kooi, C.

  National Cancer Institute

  7/1/22 → 10/31/22

  Project: Research project

• Aberrant Glycogen is a Metabolic Vulnerability of Ewing's Sarcoma

  Sun, R.

  8/1/19 → 7/31/20

  Project: Research project

• Aberrant Glycogen is a Metabolic Vulnerability of Ewing's Sarcoma

  Sun, R.

  8/1/19 → 3/31/20

  Project: Research project

• Aberrant Glycogen is a Metabolic Vulnerability of Ewing's Sarcoma

  Sun, R.

  8/1/19 → 7/31/22

  Project: Research project

• Aberrant Glycogen is a Metabolic Vulnerability of Ewing's Sarcoma

  Sun, R.

  8/1/19 → 7/31/21

  Project: Research project

• Aberrant Glycogen Modulates Cerebral Glucose Metabolism in Aging and Alzheimer's Disease

  Sun, R., Gentry, M., Johnson, L., Nelson, P., Van Eldik, L. & Wang, C.

  National Institute on Aging

  4/15/20 → 10/31/22

  Project: Research project

• Aberrant Protein Complexes as Biomarkers of Alzheimer's Disease

  Lovell, M., Lynn, B. & Markesbery, W.

  National Institute on Aging

  9/1/08 → 8/31/11

  Project: Research project

• A Better Way to Excise Inhibitory Molecules (CSPGs) from a Spinal Cord Injury Scar to Promote Regeneration

  Snow, D., Hering, T., Onifer, S. & Smith, G.

  9/30/10 → 2/28/14

  Project: Research project

• ABFM Quality Improvement Project

  Talbert, J.

  American Board of Family Medicine Incorporated

  9/1/13 → 8/31/18

  Project: Research project

• ABI Innovation: A New Framework to Analyze Plant Energy-Related Phenomics Data

  Chen, J.

  National Science Foundation

  7/1/16 → 8/31/19

  Project: Research project

• Ability of Extrates Containing Carnosic Acid (18010 and 18070) or Rosmarinic Acid (19005) to Protect the Brain from the Cognitive Defects that Occur in a Senescence Accelerated Prone Mouse Model

  Butterfield, D. A.

  St Louis University

  8/1/11 → 1/31/13

  Project: Research project

• A bio-economic study of an introduced biological control agent: ecological, evolutionary, and economic factors in sustainable agricultural systems

  Kajita, Y.

  7/15/12 → 7/19/13

  Project: Research project

• Abiotic stress and adaptive phenology in fruit and forest trees

  Abbott, A.

  12/15/15 → 12/14/19

  Project: Research project

• Ablation Modeling of Arc Jet Test Data

  Martin, A.

  Raytheon Company

  9/14/16 → 12/31/16

  Project: Research project

• ABl kinases in growth factor signaling, motility, and invasion.

  Plattner, R., Samayoa, L. & Shelton, B.

  National Institute of Health

  8/1/07 → 8/1/07

  Project: Research project